Vivo Capital VIII LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 5:22 pm Sale |
2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 0 0.000% |
-1,819,600 (Position Closed) |
Filing |
| 2021-02-12 4:30 pm Sale |
2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 1,819,600 5.500% |
-425,304 (-18.95%) |
Filing |
| 2020-06-11 5:06 pm Sale |
2019-06-10 | 13G | Crinetics Pharmaceuticals, Inc. CRNX |
Vivo Capital VIII LLC | 2,244,904 6.800% |
-853,416 (-27.54%) |
Filing |